Advertisement
Screener

NeuroSense Therapeutics Ltd. (NRSN) SEC Comment Letters

2.8 / 5 stars · 68/120 Roast Me

NeuroSense Therapeutics Ltd. SEC Comment Letters

No SEC Comment Letters for NRSN on this site yet.

Source checked: its SEC EDGAR filings (CIK 1875091).